Breast cancer
Disease Description
Breast cancer (BC) is the most common type of oncology among women. Half of breast cancer cases occur in the female population without exposure to specific risk factors and are determined solely by sex and age (the older the woman, the higher the risk).
Symptoms indicating the need to seek diagnosis and treatment
Like most types of cancer, BC does not manifest itself in the early stages. Later, as the tumor grows, the following symptoms may appear:
- Lump in the breast (initially painless)
- Pathological nipple discharge upon compression (any discharge outside pregnancy and lactation requires thorough diagnosis)
- Change in the size and shape of the breast
- Nipple retraction or change in the color and shape of the areola
- “Orange peel” effect on the breast skin
- Redness, ulcerations on the breast skin
Diagnosis and treatment methods
Diagnosis
In addition to visual examination, to establish the diagnosis, a woman must undergo mammography (tomosynthesis), breast ultrasound, and MRI. Breast cancer is definitively diagnosed after performing a biopsy, in which both tissue and fluid from the breast are collected.
Treatment
The strategy depends on the stage and subtype of cancer, taking into account its spread beyond the breast. To minimize recurrences, oncologists at the best clinics worldwide combine treatment methods, using the following as the basis:
- Surgical: surgical removal of the tumor, which can be performed using the Da Vinci robot
- Radiation therapy: to reduce the spread of cancer cells beyond the organ
- Hormone therapy: the use of hormones to reduce the activity of cancer cells
- Targeted therapy: blocking signaling pathways that stimulate cell division
- Chemotherapy: reducing the tumor using special drugs — cytostatics
Innovations in world clinics
To assess the risk of breast cancer, Western doctors conduct genetic testing for hereditary oncology. An expanded gene test is used to check DNA for mutations. The main gene responsible for the development of breast tumors is BRCA 1. The study requires only blood or saliva samples.
Top clinics
-
Seoul, South Korea
Asan Medical Center
-
Jerusalem, Israel
Hadassah Medical Center
-
Petah Tikva, Israel
Medical Center Rabin
-
Istanbul, Turkey
Istanbul Florence Nightingale Hospital
-
Geneva, Switzerland
Hirslanden Clinique La Colline
-
Geneva, Switzerland
Generale-Beaulieu
-
Baden-Baden, Germany
Max Grundig Clinic
-
Istanbul, Turkey
Acibadem Altunizade
-
Istanbul, Turkey
Medistate International Hospital
-
Antalya, Turkey
Hospital Medical Park Antalya
-
Dubai, UAE
NMC Healthcare
-
Istanbul, Turkey
Hospital Memorial Şişli
-
Milan, Italy
San Donato Hospital
-
Milan, Italy
San Raffaele University Hospital
-
Abu Dhabi, UAE
Burjeel Hospital Abu Dhabi
-
Vienna, Austria
Debling Private Clinic
-
Heidelberg, Germany
Heidelberg University Hospital
-
Hamburg, Germany
Asklepios Nord Heidberg
-
Dusseldorf, Germany
FKKD Clinical Complex
-
Winterthur, Switzerland
Clinic Lindberg
-
Incheon, South Korea
Gil Medical Center at Gachon University
-
Lausanne, Switzerland
Clinique Montchoisi
-
Nyon, Switzerland
Clinique Genolier
-
Istanbul, Turkey
Memorial Ataşehir Clinic
-
Barcelona, Spain
QuironSalud Barcelona Hospital
-
Barcelona, Spain
Medical Center Teknon
-
Barcelona, Spain
University Hospital Barnaclinic+
-
Madrid, Spain
University Hospital HM Monteprincipe
-
Hamburg, Germany
Asklepios Klinik Barmbek
-
Gebze, Turkey
Anadolu Clinic
-
Zurich, Switzerland
Hirslanden Clinic
-
Madrid, Spain
QuironSalud University Hospital
-
Lugano, Switzerland
Saint Anna Clinic
-
Geneva, Switzerland
Clinique des Grangettes
-
Duesseldorf, Germany
Oncological Center Dusseldorf
-
Seoul, South Korea
Samsung Medical Center
-
Seoul, South Korea
Medical Center at Ewha Womans University
-
Seoul, South Korea
SNUH